Certified by Founder Lodge
Newpath Partners
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $270,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields inc
| Company | Date | Round | Raised |
|---|---|---|---|
Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
Leal Therapeutics |
October, 31 ,2024 | Unknown | $45,000,000 |
Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
CREATE Medicines |
May, 14 ,2026 | Series B | $122,000,000 |
Orbital Therapeutics
Myeloid Therapeutics
Magnet Biomedicine
Leal Therapeutics
Metsera
CREATE Medicines
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)